Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Therapix Biosciences (TRPX US)
Watchlist
4
Analysis
Health Care
•
United States
Therapix Biosciences Ltd provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. Therapix Biosciences serves customers worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Therapix Biosciences
•
17 Nov 2017 22:14
•
Issuer-paid
Therapix Biosciences - Two new cannabinoid programs
Therapix is expanding its cannabinoid-based clinical pipeline beyond neurological disorders to potentially treat obstructive sleep apnea (OSA), a...
Edison Investment Research
Follow
81 Views
Share
bullish
•
Therapix Biosciences
•
18 Aug 2017 18:45
•
Issuer-paid
THX-ULD01 to focus on TBI
Therapix reported H117 results and provided a company update in which it announced that the planned development program for sublingual ultra-low...
Edison Investment Research
Follow
95 Views
Share
bullish
•
Therapix Biosciences
•
29 Jun 2017 19:37
•
Issuer-paid
Tackling neurology with cannabinoids
Therapix is investigating the potential of new formulations of cannabinoids to address underserved diseases of the brain. It recently listed on...
Edison Investment Research
Follow
115 Views
Share
bullish
•
Therapix Biosciences
•
07 Jun 2017 18:00
•
Issuer-paid
Cannabinoids for underserved diseases
Therapix recently underwent an IPO on NASDAQ in the US of 2.3m ADS (worth $13.8m) to finance the clinical development of cannabinoid products. The...
Edison Investment Research
Follow
111 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x